<unk>  is a vaccine developed for use in sub-Saharan Africa for children and adults between 9 months and 29 years of age against meningococcal bacterium Neisseria meningitidis group A. The vaccine costs less than US$0.50 per dose.
MenAfriVac
Polio vaccine
Faricimab
Zoster vaccine
CoronaVac
Hib vaccine
Typhus vaccine
Crohns MAP Vaccine